In the present study, we investigated the ability of human fetal membranes (amnion and choriodecidua) to regulate human maternal uterine cell functions through the secretion of surfactant protein (SP)-A and SP-D at the end of pregnancy. We detected the expression of both SP-A (SP-A1 and SP-A2) and SP-D by quantitative reverse transcription polymerase chain reaction. Immunohistochemistry revealed that human fetal membranes expressed both SP-A and SP-D. By Western blot analysis, we demonstrated that SP-A protein expression was predominant in choriodecidua, whereas the amnion predominantly expressed SP-D. Only the secretion of SP-A was evidenced in the culture supernatants of amnion and choriodecidua explants by immunodot blot and confirmed by Western blot. Exogenous human purified SP-A induced stress fiber formation in cultured human myometrial cells via a pathway involving Rho-kinase. Conditioned medium from choriodecidua and amnion explants mimicked the SP-A effect. Treatment of myometrial cells with SP-A-depleted conditioned medium from choriodecidua or amnion explants failed to change the actin dynamic. These data indicate that SP-A released by human fetal membranes is able to exert a paracrine regulation of F-actin filament organization in myometrial cells. myometrium; pregnancy REGULATION OF LABOR PROCESSES involves cross-talk between maternal and fetal compartments. Thus, the roles of locally produced factors acting on myometrium need further exploration. The fetal membranes are located in the vicinity of the myometrium and are then ideally positioned to regulate signaling pathways between mother and fetus at the time of labor (for review, see (1, 10, 15, 20, 22, 31, 38) and can be detected as early as 26 wk of pregnancy in amniotic fluid. SP-D levels rise only slightly during pregnancy, whereas SP-A levels rise sharply from 32 wk toward term (29, 34) and then decline in spontaneous parturition at term (3). Condon et al. (5) have described SP-A as a link between fetal lung development and the timing of labor in the mouse. Their thesis was that SP-A secreted by the fetal lung into amniotic fluid near term activates macrophages in the amniotic fluid, priming their migration to the maternal uterus and ultimately causing a functional "progesterone withdrawal" and labor through a NF-B-driven inflammation response. However, trafficking of fetal macrophages into the myometrium of women with labor at term does not occur (16, 18) . In addition, the human fetal membranes are thought to be extrapulmonary sources of SP-A and SP-D (29). To date, only the expression of SP-A1 has been found in human fetal membranes (13), and an induction of SP-A expression by cortisol has been reported in cultured chorionic trophoblasts (40).
It has been proposed that the surfactant proteins (SP) secreted from the maturing fetal lung into the amniotic fluid serve as hormones of parturition (27) . Surfactant proteins A (SP-A) and D (SP-D) are members of the collectin family that have a critical role in the innate immune response. These two hydrophilic sialoglycoproteins bind to oligosaccharides on the surface of a variety of pathogenic microorganisms (for a review, see Ref. 17) . Human SP-A is encoded by two genes, SP-A1 and SP-A2 (26) ; the two human genes are very similar in their nucleotide sequence and encode proteins that differ by eight to 10 amino acids. These two SP-A genes may also be differentially expressed in various human tissues or cells (for a review, see Ref. 8) . Human SP-D is encoded by one gene, SP-D. Both SP-A and SP-D are present in the female genital tract (1, 10, 15, 20, 22, 31, 38) and can be detected as early as 26 wk of pregnancy in amniotic fluid. SP-D levels rise only slightly during pregnancy, whereas SP-A levels rise sharply from 32 wk toward term (29, 34) and then decline in spontaneous parturition at term (3). Condon et al. (5) have described SP-A as a link between fetal lung development and the timing of labor in the mouse. Their thesis was that SP-A secreted by the fetal lung into amniotic fluid near term activates macrophages in the amniotic fluid, priming their migration to the maternal uterus and ultimately causing a functional "progesterone withdrawal" and labor through a NF-B-driven inflammation response. However, trafficking of fetal macrophages into the myometrium of women with labor at term does not occur (16, 18) . In addition, the human fetal membranes are thought to be extrapulmonary sources of SP-A and SP-D (29) . To date, only the expression of SP-A1 has been found in human fetal membranes (13) , and an induction of SP-A expression by cortisol has been reported in cultured chorionic trophoblasts (40) .
In the present study, we addressed the question of whether SP-A and SP-D originating from the human fetal membranes can directly regulate human maternal uterine cell functions. We previously reported the ability of SP-A to bind and to serve as a signal in human uterine smooth muscle cells (11) . We first analyzed the human fetal membranes (amnion and choriodecidua) for their ability to express mRNA and protein and to secrete SP-A and SP-D at the end of pregnancy. We then investigated the potential roles of SP-A and SP-D released from the human fetal membranes in the regulation of actin dynamic in human uterine smooth muscle cells.
MATERIALS AND METHODS
Reagents. Dulbecco's modified Eagle's medium (DMEM), trypsin-EDTA, penicillin-streptomycin mixture, phosphate-buffered saline (PBS) with and without calcium, fetal calf serum (FCS), oligo(dT) primers, and Moloney murine leukemia virus (M-MLV) reverse transcriptase were obtained from Invitrogen (Life Technologies, Cergy-Pontoise, France). Taq polymerase was purchased from Q Biogene (MP Biomedicals, Illkirch, France). Human lung cDNA was from Clinisciences (Montrouge, France). Electrophoresis reagents were obtained from Bio-Rad (Richmond, CA). Hybond-P membranes, enhanced chemiluminescence (ECL) detection system (ECL and ECL plus), and secondary antibodies conjugated to horseradish peroxidase were obtained from GE Healthcare Life Sciences (Orsay, France). Mouse anti-human SP-A monoclonal antibody (MAB370) and rabbit anti-mouse SP-D antibody that cross-reacts with human (AB3434) were purchased from Chemicon (Millipore, Saint Quentin-en-Yvelines, France). Rabbit-anti human SP-A antibody [H-148 (sc-13977)] and rabbit anti-human SP-D antibody [H-120 (sc-13980)] were purchased from Santa Cruz Biotechnology (Tebu-Bio, Le Perray-en-Yvelines, France). Monoclonal anti-vimentin, monoclonal anti-cytokeratin 7 (KRT7), retrieval solution, immunostaining kit (DakoCytomation LSAB ϩ system-HRP), aqueous, and fluorescent mounting medium were purchased from Dako France (Trappes, France). The Alexa fluor R 488 donkey anti-rabbit IgG was from Interchim (Montluçon, France). Inhibitor of Rho-associated kinase (Y-27632) was purchased from Calbiochem (La Jolla, CA). Kodak X-Omat XAR film, protease inhibitor cocktail (P-2714), Nonidet P-40 (N-6507), and other drugs and chemicals used were of the highest quality available from SigmaAldrich (Saint Quentin Fallavier, France).
Biological samples. Placentas with attached fetal membranes from term normal uncomplicated singleton pregnancies were collected after elective caesarian section prior to the onset of labor (range: 38.5-40 wk of pregnancy), because of a diagnosed cephalo-pelvic disproportion in normal pregnancy, at the Port-Royal Cochin Hospital (Paris, France). All patients gave informed consent. Fetal membranes were dissected free of the placenta under sterile conditions and washed with PBS to eliminate blood clots.
Biopsies of myometrium were obtained from pregnant women who delivered by elective cesarean section performed before the onset labor (range: 38.5-40 wk of gestation). Myometrial strips were taken from the upper edge of the hysterotomy in the transverse lower uterine segment during caesarean section. Myometrial tissue from the outer uterine wall at an extra placental site was removed by sharp dissection, leaving behind the decidua. Tissue was then carefully minced with fine scissors before rapid placement in culture medium. The study was approved by the "Comité de Protection des Personnes, Ile de France III" (no. P040104), and informed consent was obtained from all donors.
Fetal membrane explants. The fetal membranes were collected at 2 cm from the placental edge, and the amnion was carefully peeled from the chorion with adherent decidua. Tissue explants excised with a scalpel into 1-cm squares were pooled and distributed randomly. Ten pieces per well of each membrane were placed in six-well plates containing 5 ml of culture medium (DMEM supplemented with 10% FCS, 100 U/ml of penicillin, and 100 g/ml of streptomycin). The explants were incubated under 5% CO 2 and 95% air at 37°C for 12 h to allow them to stabilize as described previously (19) . The explants were then incubated for 24 h in 2 ml of serum-free medium. At the end of the incubation period, the explants of each well were pooled, weighted, and immediately frozen in liquid nitrogen before storing at Ϫ80°C until further analysis. The culture media were immediately frozen in liquid nitrogen and stored at Ϫ80°C for SP-A and SP-D assay or used freshly as amnion-conditioned media and choriodecidua-conditioned media. The cell viability of the explants, which was checked at the end of experiments by trypan blue exclusion after trypsin and collagenase digestion of the membranes, was 96 -99% (data not shown).
Myometrial cell culture. After collection, the myometrial biopsies were placed in DMEM supplemented with 100 U/ml penicillin and 100 g/ml streptomycin. Human uterine smooth muscle cells were obtained by the explants method, as described previously (6) . Cells were cultured in DMEM supplemented with antibiotic solution and 10% FCS and routinely passaged when 90 -95% of cells were confluent. Confluent myometrial cells were identified by their typical "hill and valley" microscopic appearance and by their positive reaction to a monoclonal antibody raised against smooth muscle ␣-actin. The experiments presented in this study were performed with cells between their third and fifth passages, with no noticeable difference between results obtained with cells from individual passages and with cells obtained from different uteri. Each population of myometrial cells studied has been taken from a different patient.
Cell stimulation. Confluent myometrial cells were incubated for 3 days in serum-free medium to achieve quiescence. Then, cells were incubated either without (control) or with SP-A (20 g/ml) and SP-D (20 g/ml) for the indicated times. In another set of studies, subconfluent myometrial cells were cultured in serum-free medium, and amnion-or choriodecidua-conditioned medium was added (50% vol/ vol) for the indicated times.
Isolation of SP-A and SP-D. Native human SP-A was purified from the bronchoalveolar lavage fluids of patients with alveolar proteinosis by sequential butanol and octyl glucoside extractions (14) , as described previously (10, 11) . The content of endotoxin in SP-A preparations was estimated by limulus amebocyte lysate method (BioWhittaker) and was 0.12 pg/g protein. SP-D was isolated from supernatants of bronchoalveolar lavage fluids with maltose-agarose affinity chromatography, high-salt wash, and manganese solution, as described previously (30) . SP-D eluted by manganese was concentrated and further purified by suprose 6 gel filtration chromatography.
Immunohistochemistry. Immediately after the cesarean section, full-thickness fetal membranes from four term placentas were fixed in 4% formalin for 4 h at room temperature and then embedded in paraffin. Tissue sections of 5 m were mounted on slides and dewaxed in xylene and rehydrated in ethanol-water. Immunostaining was performed with a universal streptavidin-peroxidase immunostaining kit. Nonspecific binding was blocked by incubation of tissue sections in 3% serum albumin in PBS buffer for 30 min, and endogen peroxidase activity was inhibited by incubation in 3% hydrogen peroxide for 5 min. The sections were incubated with the polyclonal rabbit anti-human SP-A antibody (1/200), the polyclonal rabbit antihuman SP-D antibody (1/200), vimentin (1/200), or KRT7 (1/200) for 30 min at room temperature. Sections were washed in PBS and incubated with a biotinylated secondary antibody for 15 min. They were then washed three times in PBS and incubated with streptavidin conjugated to horseradish peroxidase for 15 min. The sections were washed in PBS, and staining was detected by incubation with the 3,3=-diaminobenzidine-tetrahydrochloride chromogen. Controls were performed by incubating the tissue sections with nonspecific rabbit or mouse purified immunoglobulins at the same concentration as the primary antibodies. Preparations were counterstained with hematoxylin blue and mounted in an aqueous mounting medium and then examined and photographed with an Olympus BX60 microscope.
Western blot analysis. Whole homogenates were prepared from matched amnion and choriodecidua explants as indicated. Tissues (400 mg/ml) were homogenized with an Ultra-Turrax apparatus (IKA-WERKE) in ice-cold homogenization buffer (100 mM Tris·HCl, pH 7.4, 2 mM MgSO4, 2 mM EDTA, 10% glycerol, and protease inhibitor cocktail). The protein concentrations were determined by the method of Bradford, using bovine serum albumin as standard. Equal amounts of proteins (25 g) were resolved by SDS-PAGE on 10% gels and transferred onto a Hybond-P membrane. Nonspecific binding sites were blocked by incubating the membranes with 5% low-fat dried milk in Tris-buffered saline-Tween (TBST; 10 mM Tris·HCl, pH 7.5, 0.15 M NaCl, 0.1% Tween-20). The membranes were then incubated overnight at 4°C in TBST-1% milk with the indicated antibodies at the appropriate concentrations: monoclonal antibody directed against SP-A (1/300) and polyclonal antibody directed against SP-D (1/4,000). Membranes were washed with TBST and incubated with either goat-anti mouse or donkey anti-rabbit secondary antibody conjugated with horseradish peroxidase. The blots were developed with ECL reagents and visualized on Kodak X-ray films. Molecular weight markers were run in parallel.
For standardization, the membranes were stripped with a buffer containing 62.5 mM Tris (pH 6.2), 2% sodium dodecyl sulfate, and 100 mM ␤-mercaptoethanol at 50°C for 30 min and reprobed with a polyclonal antibody raised against GAPDH (1/1,000). Densitometric analysis was performed using the National Institutes of Health (NIH) Image J software (http://rsb.info.nih.gov/ij) developed by W. S. Rasband (NIH, Bethesda, MD) and allowed us to control that the intensity of the signal for GAPDH exhibited no statistical difference in all of the samples of fetal membranes studied.
SP-A-immunodepleted media. Amnion-and choriodecidua-conditioned media were subjected to SP-A immunoprecipitation. Briefly, 500 l of conditioned media (0.5 mg protein) was centrifuged at 10,000 g for 10 min to eliminate cellular debris. The supernatant was incubated overnight at 4°C on a rocker platform with 25 l of a polyclonal rabbit antibody against SP-A or with nonimmune rabbit IgG. Then, 25 l of Pierce Protein G Plus-Agarose (Thermo Fisher Scientific, Brebieres, France) preequilibrated with PBS was added. After 3 h at 4°C to remove antibody and antibody-antigen conjugates, samples were centrifuged. After four washes in cold PBS, unbound proteins were recovered after centrifugation at 5,000 g for 5 min and either stored at Ϫ80°C or used freshly as partial SP-A-immunodepleted conditioned media. The extent of residual SP-A present in the supernatants was checked by Western blot with a monoclonal antibody against SP-A.
Immunodot blot. Amnion-and choriodecidua-conditioned media were centrifuged to remove any cellular debris. SP-A and SP-D were assayed by quantitative dot blotting. Duplicate dots of samples (10 l) and several dilutions of purified lung SP-A and SP-D were applied directly to a polyvinylidene difluoride membrane by vacuum using a 24-well dot blot apparatus. Nonspecific binding sites were blocked by a 1-h incubation in a solution of TBST containing 5% low-fat milk. The membrane was incubated overnight at 4°C with a monoclonal antibody directed against SP-A (1/300) and a polyclonal antibody directed against SP-D (1/4,000) in TBST containing 1% low-fat milk. After 3 washes for 10 min with TBST, blots were then incubated for 45 min at RT with secondary antibody goat anti-mouse IgG for SP-A and a donkey anti-rabbit IgG for SP-D (1:30,000), both conjugated with horseradish peroxidase and then washed as in the previous step. The blots were incubated with ECL reagents and exposed to Kodak X-Omat XAR film. The film was developed, and the dot intensities were quantified by densitometric analysis.
Immunofluorescence analysis. Subconfluent myometrial cells were cultured for 2 days in 24-well dishes on coverslips and then transferred to serum-deprived media for 48 h, as described previously (7) . Quiescent cells were incubated for 30 min with 20 g/ml SP-A or SP-D in serum-free medium at 37°C. In a parallel set of studies, myometrial cells were incubated for 30 min in serum-free medium before the addition of conditioned medium (amnion or choriodecidua), SP-A immunodepleted (50% vol/vol final concentration) or not.
After fixation for 15 min with 4% paraformaldehyde in PBS, cells were rendered permeable by incubation in 0.1% Triton X-100 in 10% FCS-PBS for 15 min. Filamentous actin (F-actin) pools were then stained with tetramethyl rhodamine isothiocyanate (TRITC)-labeled phalloidin (1 g/ml) in 0.1% Triton X-100 in 10% FCS-PBS for 45 min at room temperature, protected from light. When Rho-kinase inhibitor was used, myometrial cells were exposed for 45 min to this drug at the appropriate concentration and then to SP-A or SP-D. Coverslips were mounted on slides using fluorescent mounting medium. A Nikon E-600 microscope was used for conventional fluorescence microscopy, and photographs were taken using Coolsnap Software (RS Photometrics, Evry, France).
F-actin staining intensity within cells was measured with NIH Image J. The time of image captures, the image intensity gain, the image enhancement, and the image black level were optimally adjusted at the onset and kept constant for all experiments. Images were captured in duplicate from each well and were digitized (561 ϫ 446 pixels) with a color resolution from 0 (minimum) to 255 (maximum) intensity. For each experiment, F-actin staining intensity of Ն30 cells from 10 fields was averaged as a single data point.
RNA preparation. Total RNA was extracted from matched amnion and choriodecidua samples using the TRIzol reagent method (Invitrogen Life Technologies, Cergy-Pontoise, France), as described previously (32) . Briefly, explants were homogenized in TRIzol reagent, and total RNA was recovered by phenol-chloroform extraction, isopropanol precipitation, and 70% ethanol washes according to the manufacturer's instructions. Total RNA was quantified by spectrophotometry, and RNA integrity was verified by nondenaturing agarose electrophoresis.
Synthesis of human cDNA for SP-A1, SP-A2, and SP-D. Reverse transcription was performed on 1 g of total RNA extracted from amnion and choriodecidua samples at 37°C with oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer and M-MLV RT. Reaction mixture for polymerase chain reaction (PCR), including Taq polymerase, was prepared as suggested by the manufacturer. Primers (Table 1) were designed using Primer Express software (Applied Biosystems, Life Technologies, Courtaboeuf, France). The identity of all PCR products was confirmed by DNA sequencing (Beckman Coulter Genomics, Takeley, UK) and sequence homology analysis using the NCBI Basic Local Alignment Search Tool (2). These fragments were used as templates for the real-time PCR standard curves.
Real-time PCR analysis. Five independent fetal membranes (matched amnion and choriodecidua) were analyzed in duplicate. Before doing real-time PCR, the samples were checked for any DNA contamination by performing PCR reactions done without reverse transcription of the RNA extracts. For each transcript to study, real-time PCR was carried out using the real-time Applied 7000 PCR system (Applied Biosystems, Life Technologies) with 5% of the retrotranscribed product (equivalent to 50 ng of RNA) and 0.3 mM of gene-specific oligonucleotide pairs in a total volume of 25 l of reagent SYBR Green PCR Mastermix (Applied Biosystems, Life Technologies). Standard curves were generated in parallel using serial dilutions of the purified PCR products as polymerase templates. The presence of a specific and unique PCR product was verified by an ABI prismgenerated melting curve profile (Supplemental Figures; Supplemental Material for this article is available at the AJP-Endocrinology and Metabolism web site). Quantification of targets was calculated from their respective standard curves and was expressed as number of RNA copies per 50 ng total retrotranscribed RNA. No significant difference in the expression for the reference GAPDH mRNA was detected (ANOVA, P Ͻ 0.05) between the different tissues (amnion, choriodecidua) studied. Therefore, for each sample investigated by PCR, the target gene expression values were normalized to the corresponding value for GAPDH.
Statistical analysis. Results are expressed as means Ϯ SE. Statistical significance was determined using one-way ANOVA followed by post hoc tests with StatView software (SAS Institute, Cary, NC). Values at P Ͻ 0.05 were considered statistically significant. Fig. 1) . All samples were normalized with respect to GAPDH. In both components of fetal membranes, we detected lower mRNA copy number of SP-A1 and SP-A2 than copy mRNA number of SP-D. No statistically significant differences were observed for the levels of expression of SP-A1, SP-A2, or SP-D between amnion and choriodecidua.
RESULTS

Expression of SP-A1, SP-A2, and SP-D mRNA in amnion and choriodecidua. Expression of SP-A1, SP-A2, and SP-D was analyzed by quantitative RT-PCR in matched amnion and choriodecidua (
Expression of SP-A and SP-D proteins in amnion and choriodecidua. Expression of SP-A and SP-D proteins was
analyzed by Western blotting on matched amnion and choriodecidua samples. As shown in Fig. 2A , SP-A immunoblot analysis revealed an immunoreactive band of the predicted size (33 kDa) in both fetal membranes and in rat lung (used as a positive control). In the choriodecidua, the level of SP-A was higher compared with the amnion (Fig. 2A) . Immunosignals of the predicted size for SP-D (2 monomers of ϳ46 and 43 kDa) were found in the amnion and in the lung tissue. The intensity of the immunoreactive bands for SP-D (Fig. 2B ) was more pronounced in homogenates of amnion than in homogenates of choriodecidua.
Immunolocalization of SP-A and SP-D in the human fetal membranes. Chorionic trophoblasts were evidenced using KRT7, as shown in Fig. 3 . The amniotic epithelium was positive for KRT7 in some samples, whereas the decidua did not stain with KRT7. Vimentin was used to identify the mesenchymal layer of the amnion and the decidual stromal cells. Positive immunostaining for SP-A was found mainly in trophoblast cell layer of the chorion leave and in amnion epithelial cells. Decidual cells also showed positive SP-A immunoreactivity. A pattern of staining for immunoreactive SP-D was clearly observed in the chorion leave and in the decidual cells, and faint staining was also seen in the amniotic epithelial cells. The immunostaining was abolished when nonimmune serum was substituted to the primary antibody.
SP-A and SP-D determinations in amnion-and choriodecidua-conditioned media.
An equivalent volume of amnionand choriodecidua-conditioned media was tested for detecting the presence of SP-A and SP-D using immunodot blot analysis. We initially performed a standard curve by blotting serial dilutions of purified lung SP-A or SP-D to ensure that our determinations were in the linear range of detection and that the loading was appropriate for the binding capacity of the polyvinylidene difluoride membrane and the concentration of the antibody used. A dose-response curve for SP-A was observed between 0.004 and 0.06 g of SP-A with a plateau ϳ0.12 g, and a dose response-curve for SP-D was observed between 0.015 and 0.06 g for SP-D with a plateau ϳ0.24 g (data not shown). As shown in Fig. 4A , SP-A proteins were clearly detected by immunodot blot in all samples of conditioned media, with higher levels of SP-A found in choriodecidua-conditioned media. We performed an additional Western blot with the same conditioned media (Fig. 4B) . In both amnion-and choriodeciduaconditioned media, we observed a faint immunoreactive band at ϳ33 kDa and corresponding to the SP-A monomer as well as a doublet with major bands at ϳ60 -66 kDa representing the dimer forms of SP-A, as reported previously in the lung (37) . The 66-kDa band was, in addition to the expected 33-kDa band, detected in the rat lung, used as a positive control. By contrast, combined data from immunodot blot followed by Western blot analysis did not confirm the presence of SP-D proteins in both amnion-and choriodecidua-conditioned media (data not shown).
Effects of amnion-and choriodecidua-conditioned media on formation of F-actin fibers in human cultured myometrial cells.
We first evaluated the ability of exogenous SP-A to induce actin stress fibers as an indicator of cytoskeleton reorganization in myometrial cells. F-actin is the major microfilament of stress fibers. As we demonstrated previously (11), exposure of myometrial cells to an optimal concentration of SP-A (20 g/ml) for 30 min resulted in an increase of the TRITC-phalloidin staining intensity of F-actin compared with untreated cells (Fig. 5) . Pretreatment of the myometrial cells with the selective Rho-kinase inhibitor Y-27632 (10 M) for 45 min markedly attenuated stress fiber formation induced by SP-A. By contrast, neither treatment with SP-D (20 g/ml) nor Rho-kinase inhibitor alone had an effect on actin reorganization. We next evaluated the contribution of SP-A released from the amnion and choriodecidua explants to modify myometrial cell actin organization. Conditioned media from amnion and choriodecidua explants induced the formation of stress fibers (Fig. 6) . To determine whether SP-A contributed to the ability of amnion and choriodecidua to induce formation of F-actin fibers, SP-A was subtracted from amnion-and choriodeciduaconditioned media by immunoprecipitation, and the effect on cytoskeleton organization was examined. Western blot confirmed subtraction but not complete removal of SP-A from conditioned media by this method (Fig. 4C) . Exposure of myometrial cells to SP-A-depleted amnion-conditioned media or to SP-A-depleted choriodecidua-conditioned media led to a significant attenuation of the stress fiber formation (Fig. 6) . When conditioned media were treated in the same condition used for SP-A depletion but with isotypic IgG, no difference in stress fiber formation was observed compared with nondepleted SP-A conditioned media.
DISCUSSION
The present study demonstrated that both components of human fetal membranes express SP-A1, SP-A2, and SP-D. Moreover, RT-PCR analysis revealed that matched amnion and choriodecidua display similar amounts of SP-A1, SP-A2, and SP-D mRNAs. In a previous analysis of chorioamniotic membranes at the end of pregnancy by Han et al. (13) , predominant expression of SP-A1 mRNA has been observed with an increased expression associated with chorioamnionitis. The fact that studies have been performed on intact or separated fetal membranes may contribute to the apparent discrepancy.
As determined by immunohistochemistry, detection of SP-A and SP-D in chorionic trophoblastic cells and amnion epithelial cells, as well as in decidual cells, is consistent with the results of previous studies (13, 29, 40) . SP-A and SP-D have previously been shown to be located in cell lining surface epithelium and secretary glands in the lower genital tract in humans (20, 21) . These results are in accord with previous reports showing that SPs are expressed mainly of surface epithelia in extrapulmonary tissues (22, 23) . Western blot analysis confirmed the presence of SP-A protein, which is more expressed in the choriodecidua than in amnion. However, we cannot discriminate SP-A1 or SP-A2 at the protein levels in the present study because of the lack of commercially available SP-A1 and SP-A2 antibodies.
Moreover, we observed that the amnion preferentially express SP-D, as evidenced by immunodetection of a strong SP-D signal. Whether this regional distribution within the fetal membrane is of physiological significance needs to be determined. There is evidence of some species variation in SP-A and SP-D expression in the female genital tract. SP-A and SP-D were originally demonstrated in the genital tracts of mares (15) and mice (31) , but in this species SP-A was clearly detected in uterus, whereas SP-D expression was demonstrated in fetal membrane and in placenta (38) . SP-A was immunodetected in both the human and rat myometrium at the end of gestation, but no RT-PCR signal was found in rat when RNA from whole myometrium throughout pregnancy was used as template (10, 11) .
Using dot blot analysis, both SP-A and SP-D were detected in all conditioned media from amnion and choriodecidua samples. However, the signal detected for SP-D in conditioned media was not confirmed by Western blot analysis, suggesting that SP-D is either absent or in a quantity below the detection limit. An alternative explanation could be that SP-D has been trapped by some apoptotic cells generated in the fetal membrane explants during the time frame of the experiment, as demonstrated by Palaniyar et al. (33) . However, this seems less probable because we previously checked the cell viability of the explants throughout the culture. The presence of SP-A was nonetheless confirmed by Western blot analysis, since two molecular masses of ϳ33 (monomer) and 60 -66 kDa (dimers) were immunodetected. We hypothesized that proteins might have reaggregated, as reported previously (37) . These data support previous in vitro results of Sun et al. (40) , suggesting that SP-A can be synthesized locally in human fetal membranes. These authors also reported induction of SP-A expression by cortisol in human chorionic trophoblasts. Additionally, whether SP proteins are also synthesized by human fetal membranes in vivo, whether SP synthesis may be influenced and/or regulated by different stimuli, and whether they contribute to amniotic fluid SP-A and SP-D levels at the end of pregnancy (29) is yet to be determined.
Then, it might be proposed that SP-A originating from the fetal membranes regulates human myometrial functions at the end of pregnancy, participating in a network of signaling pathways that needs to cooperate for the parturition process. In line with this proposal, we first confirmed our previous data indicating that human cultured myometrial cells expressed functional binding sites and respond to purified SP-A to induce stress fiber formation via a pathway involving Rho-kinase (11) . In human myometrium, Rho-kinase inhibition has been associated with reduction of uterotonic-induced myometrial contractions (9, 12, 35) . We confirmed that pharmacological inhibition of Rho-kinase resulted in a clear reduction of stress fiber formation induced by SP-A. By contrast, SP-D did not affect actin staining. We then focused to demonstrate the functional activity of SP-A originated from the fetal membranes. Myometrial cells were then cultured with conditioned media from choriodecidua and amnion explants after SP-A immunoprecipitation. We observed that conditioned media from choriodecidua and amnion explants were able to mimic the effect of exogenous human purified SP-A on stress fiber formation, Fig. 6 . Effects of CM from amnion and choriodecidua explants on stress fiber formation in human cultured myometrial cells. Myometrial cells were grown on coverslips, serum-starved for 48 h, and incubated for 30 min without (control) or with 20 g/ml human purified SP-A; CM from matched amnion and choriodecidua explants depleted or not of SP-A by immunoprecipitation. Cells were fixed and permeabilized, and F-actin pools were stained with TRITC-phalloidin. This figure is representative of 4 independent experiments (myometrial cells cultured from 3 separate patients; CM of matched amnion and choriodecidua from 3 separate placentas). Original magnification ϫ400. The F-actin content of the cells was quantified by measuring the fluorescence intensity using Image J software. The integrated density (arbitrary units) is representative of 3 independent experiments that we carried out using duplicate samples. *P Ͻ 0.05, significant difference compared with control; †P Ͻ 0.05, significant difference compared with SP-A-immunodepleted CM-amnion; ‡P Ͻ 0.05, significant difference compared with SP-A-immunodepleted CM-choriodecidua.
suggesting that SP-A was released by human fetal membranes and capable of acting in a paracrine fashion. This interpretation was supported by our results demonstrating that treatment of myometrial cells with SP-A-depleted conditioned media from choriodecidua or amnion explants failed to induce any change at the level of F-actin staining or a rearrangement of F-actin fibers. However, we cannot exclude that other humoral factor(s) secreted by fetal membrane may regulate cytoskeleton organization in human pregnant myometrial cells, a pivotal process in cell motility, secretion, and contraction.
These findings raise the question of the function of SP-A and SP-D in human fetal membrane and whether they may represent an additional source of SP-A at the end of pregnancy. Mouse models of SP-A and SP-D deficiency reveal increased inflammatory responses to infection, findings that illustrate the anti-inflammatory nature of these proteins (25) . It is likely that SP-A and SP-D are involved in the recognition and clearance of pathogens from the fetal membrane and amniotic fluid via amnion cells or decidual macrophages (24) . An increase in SP-A expression in fetal membranes with chorioamnionitis has been demonstrated (13) , supporting evidence of the engagement of the innate immune response in the context of chorioamnionitis and intra-amniotic infection, a major cause of preterm labor and delivery and premature rupture of membrane (36) . The fact that human myometrial cells respond to SP-A to initiate activation of signaling events at the end of pregnancy provides new insight into the possible roles of this multifunctional protein in parturition. However, the chronological events or causal relationships would be difficult to specify. Building complementary studies on appropriate animal models of parturition (28) would be a challenge for future. In addition, it is not clear whether or not SP-A and SP-D are synthesized locally in the fetal membranes or whether they participate in the initiation of parturition. No increase in SP-A expression was noticed in human fetal membranes in spontaneous labor at term (40) . Although SP-A has been proposed as a link between fetal lung development and the timing of labor in the mouse (5), further evidence is required to propose such a role of SP-A as an essential signal for human parturition.
